Clinical use of dendritic cells for cancer therapy - The Lancet Oncology
Managing immunosuppressive therapy in potentially cured post‐kidney transplant cancer (excluding non‐melanoma skin cancer): an overview of the available evidence and guidance for shared decision‐making - Hellemans - 2021 - Transplant International -
Perspectives of solid organ transplant recipients on medicine‐taking: Systematic review of qualitative studies - Tang - 2021 - American Journal of Transplantation - Wiley Online Library
Frontiers | Immunosuppression in Glioblastoma: Current Understanding and Therapeutic Implications
IJMS | Free Full-Text | The Efficacy of Tumor Mutation Burden as a Biomarker of Response to Immune Checkpoint Inhibitors
Tumor mutational burden and immunotherapy in gliomas: Trends in Cancer
Cells | Free Full-Text | Immunosuppressive Effects of Myeloid-Derived Suppressor Cells in Cancer and Immunotherapy
Zoledronic Acid–Gadolinium Coordination Polymer Nanorods for Improved Tumor Radioimmunotherapy by Synergetically Inducing Immunogenic Cell Death and Reprogramming the Immunosuppressive Microenvironment | ACS Nano
Clinical challenges in cancer patients with COVID-19: Aging, immunosuppression, and comorbidities | Aging
Frontiers | Dissecting the Multiplicity of Immune Effects of Immunosuppressive Drugs to Better Predict the Risk of de novo Malignancies in Solid Organ Transplant Patients
Mutational burden, MHC-I expression and immune infiltration as limiting factors for in situ vaccination by TNFα and IL-12 gene electrotransfer - ScienceDirect
Transplantology | Free Full-Text | Strategies to Improve Immune Suppression Post-Liver Transplantation: A Review
ER Stress Regulates Immunosuppressive Function of Myeloid Derived Suppressor Cells in Leprosy that Can Be Overcome in the Presence of IFN-γ - ScienceDirect
Frontiers | The immunosuppressive microenvironment and immunotherapy in human glioblastoma
Corticosteroid and Immunosuppressant Therapy for Cardiac Sarcoidosis: A Systematic Review | Journal of the American Heart Association
Patient-centred approaches for the management of unpleasant symptoms in kidney disease | Nature Reviews Nephrology
Role of tumor microenvironment in EGFR-mutated NSCLC in influencing... | Download Scientific Diagram
Frontiers | Tumor Burden and Immunotherapy: Impact on Immune Infiltration and Therapeutic Outcomes
H.R. 5534 Passed: Lifetime Medicare Coverage of Immunosuppressant for Kidney Recipients - American Transplant Foundation
Nanomedicines modulating tumor immunosuppressive cells to enhance cancer immunotherapy - ScienceDirect
Peritumoral CD90+CD73+ cells possess immunosuppressive features in human non-small cell lung cancer - eBioMedicine
Myeloid immunosuppression and immune checkpoints in the tumor microenvironment | Cellular & Molecular Immunology
